Suchergebnisse - "Hirata, Haruhiko"

PubPharm (154)

11

Disseminated non-tuberculous mycobacterial infection caused by Mycobacterium obuense in an immunocompromised patient : a case report

enthalten in: BMC infectious diseases | 2023

von Naito, M. | Fukushima, K. | Kusakabe, S. | +13

12

Disseminated non-tuberculous mycobacterial infection caused by Mycobacterium obuense in an immunocompromised patient: a case report

enthalten in: BMC infectious diseases | 2023

von Naito, M. | Fukushima, K. | Kusakabe, S. | +13

13

Disseminated non-tuberculous mycobacterial infection caused by Mycobacterium obuense in an immunocompromised patient: a case report

enthalten in: BMC infectious diseases | 2023

von Naito, M. | Fukushima, K. | Kusakabe, S. | +13

14

Single-cell analyses and host genetics highlight the role of innate immune cells in COVID-19 severity

enthalten in: Nature genetics | 2023

von Edahiro, R. | Shirai, Y. | Takeshima, Y. | +124

15

Impact of minocycline on outcomes of EGFR-mutant non-small cell lung cancer patients treated with EGFR-TKIs

enthalten in: Scientific reports | 2023

von Tone, M. | Iwahori, K. | Shiroyama, T. | +10

16

Tumor-derived semaphorin 4A improves PD-1-blocking antibody efficacy by enhancing CD8+ T cell cytotoxicity and proliferation

enthalten in: Science advances | 2023

von Naito, Y. | Koyama, S. | Masuhiro, K. | +40

17

Inflammatory Cell Infiltration Into Islets Without PD-L1 Expression Is Associated With the Development of Immune Checkpoint Inhibitor-Related Type 1 Diabetes in Genetically Susceptible Patients

enthalten in: Diabetes | 2023

von Kawata, S. | Kozawa, J. | Yoneda, S. | +17

18

Virtual fluoroscopic preprocedural planning using Ziostation2 for transbronchial biopsy : A prospective self-controlled study

enthalten in: Respiratory investigation | 2023

von Abe, Y. | Miyake, K. | Shiroyama, T. | +4

19

Establishment and clinical application of SARS-CoV-2 catch column

enthalten in: Clinical and experimental nephrology | 2023

von Isaka, Y. | Yoshiya, T. | Ono, C. | +16

20

Combination of WFDC2, CHI3L1, and KRT19 in Plasma Defines a Clinically Useful Molecular Phenotype Associated with Prognosis in Critically Ill COVID-19 Patients

enthalten in: Journal of clinical immunology | 2023

von Ebihara, T. | Matsubara, T. | Togami, Y. | +9